Search

Your search keyword '"Caterson, Ian"' showing total 9 results
Start Over Author "Caterson, Ian" Publisher american diabetes association
9 results on '"Caterson, Ian"'

1. Association of hypoglycemic treatment regimens with cardiovascular outcomes in overweight and obese subjects with type 2 diabetes: a substudy of the SCOUT trial

Author

Ghotbi, Adam Ali, Kober, Lars, Finer, Nick, James, W. Philip T., Sharma, Arya M., Caterson, Ian, Coutinho, Walmir, Van Gaal, Luc F., Torp-Pedersen, Christian, and Andersson, Charlotte

Subjects
Stroke (Disease) -- Care and treatment -- Health aspects, Heart attack -- Care and treatment -- Health aspects, Obesity -- Care and treatment -- Health aspects, Diabetes therapy -- Health aspects, Hypoglycemic agents -- Health aspects, Cardiovascular diseases -- Care and treatment -- Health aspects, Weight reducing preparations -- Health aspects, Type 2 diabetes -- Care and treatment -- Health aspects, Health
Abstract

OBJECTIVE--To assess the association of hypoglycemic treatment regimens with cardiovascular adverse events and mortality in a large population of type 2 diabetic patients at increased cardiovascular risk. RESEARCH DESIGN AND [...]

Published
2013
Full Text
View/download PDF

2. The effect of a novel low-volume aerobic exercise intervention on liver fat in type 2 diabetes: a randomised controlled trial

Author

Sabag, Angelo, primary, Way, Kimberley L., primary, Sultana, Rachelle N., primary, Keating, Shelley E., primary, Gerofi, James A., primary, Chuter, Vivienne H., primary, Byrne, Nuala M., primary, Baker, Michael K., primary, George, Jacob, primary, Caterson, Ian D., primary, Twigg, Stephen M., primary, and Johnson, Nathan A., primary

Published
2020
Full Text
View/download PDF

3. Insulin response to an intravenous glucose load during development of obesity in gold thioglucose-injected mice

Author

Blair, Stephen C., Caterson, Ian D., and Cooney, Gregory J.

Subjects
Obesity -- Development and progression -- Complications and side effects, Insulin resistance -- Development and progression -- Complications and side effects, Type 2 diabetes -- Complications and side effects -- Development and progression, Health, Complications and side effects, Development and progression
Abstract

The insulin secretory response to an intravenous glucose load was examined in chronically catheterized, conscious mice 2,5, and 10 wk after induction of obesity by a single injection of gold [...]

Published
1993

4. The Effect of a Novel Low-Volume Aerobic Exercise Intervention on Liver Fat in Type 2 Diabetes: A Randomized Controlled Trial.

Author

Sabag, Angelo, Way, Kimberley L., Sultana, Rachelle N., Keating, Shelley E., Gerofi, James A., Chuter, Vivienne H., Byrne, Nuala M., Baker, Michael K., George, Jacob, Caterson, Ian D., Twigg, Stephen M., and Johnson, Nathan A.

Subjects
TYPE 2 diabetes, AEROBIC exercises, RANDOMIZED controlled trials, HIGH-intensity interval training, FAT, OBESITY complications, ADIPOSE tissue physiology, OBESITY treatment, OBESITY, LIVER, GENETIC disorders, EXERCISE, LIPID metabolism disorders, ADIPOSE tissues, EXERCISE therapy, DISEASE complications
Abstract

Objective: The aim of this study was to examine the effect of a novel low-volume high-intensity interval training (HIIT), moderate-intensity continuous training (MICT), or placebo (PLA) intervention on liver fat, glycemia, and cardiorespiratory fitness using a randomized placebo-controlled design.Research Design and Methods: Thirty-five inactive adults (age 54.6 ± 1.4 years, 54% male; BMI 35.9 ± 0.9 kg/m2) with obesity and type 2 diabetes were randomized to 12 weeks of supervised MICT (n = 12) at 60% VO2peak for 45 min, 3 days/week; HIIT (n = 12) at 90% VO2peak for 4 min, 3 days/week; or PLA (n = 11). Liver fat percentage was quantified through proton MRS.Results: Liver fat reduced in MICT (-0.9 ± 0.7%) and HIIT (-1.7 ± 1.1%) but increased in PLA (1.2 ± 0.5%) (P = 0.046). HbA1c improved in MICT (-0.3 ± 0.3%) and HIIT (-0.3 ± 0.3%) but not in PLA (0.5 ± 0.2%) (P = 0.014). Cardiorespiratory fitness improved in MICT (2.3 ± 1.2 mL/kg/min) and HIIT (1.1 ± 0.5 mL/kg/min) but not in PLA (-1.5 ± 0.9 mL/kg/min) (P = 0.006).Conclusions: MICT or a low-volume HIIT approach involving 12 min of weekly high-intensity aerobic exercise may improve liver fat, glycemia, and cardiorespiratory fitness in people with type 2 diabetes in the absence of weight loss. Further studies are required to elucidate the relationship between exercise-induced reductions in liver fat and improvements in glycemia. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

5. Waist circumference thresholds provide an accurate and widely applicable method for the discrimination of diabetes

Author

Huxley, Rachel, Barzi, Federica, Lee, Crystal M. Y., Lear, Scott, Shaw, Jonathan, Tai, Hing Lam, Caterson, Ian, Azizi, Fereidoun, Patel, Jeetesh, Suriyawongpaisal, Paibul, Sang, Woo Oh, Kang, Jae-Heon, Gill, Tim, Zimmet, Paul, James, Philip T., Woodward, Mark, Huxley, Rachel, Barzi, Federica, Lee, Crystal M. Y., Lear, Scott, Shaw, Jonathan, Tai, Hing Lam, Caterson, Ian, Azizi, Fereidoun, Patel, Jeetesh, Suriyawongpaisal, Paibul, Sang, Woo Oh, Kang, Jae-Heon, Gill, Tim, Zimmet, Paul, James, Philip T., and Woodward, Mark

Published
2007

7. Immediate Response of Waist Circumference to Sibutramine in High-Risk Diabetic and Non-Diabetic Patients - An Analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial.

Author

Finer, Nick, Caterson, Ian, Coutinho, Walmir, Gaal, Luc Van, Maggioni, Aldo, Sharma, Arya M., Torppedersen, Christian, and James, Philip

Subjects
*CLINICAL trials, *SIBUTRAMINE, *BODY weight, *OVERWEIGHT persons, *PEOPLE with diabetes, *CARDIOVASCULAR diseases, *DISEASE risk factors
Abstract

The article presents information on the SCOUT trial that assesses the ability of sibutramine to reduce waist circumference and body weight in obese and overweight patients with and without diabetes at a high risk of a cardiovascular event. A 10 mg of sibutramine with weight management were given to patients. It says that more than 80% of the patients had diabetes and another risk factor.

Published
2007

8. Clinically Relevant Weight Loss Achieved with Sibutramine in High-RiskType 2 Diabetic Patients - An Analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial.

Author

Gaal, Luc Van, Caterson, Ian, Coutinho, Walmir, Finer, Nick, Maggioni, Aldo, Sharma, Aryam, Torppedersen, Christian, and James, Philip

Subjects
*SIBUTRAMINE, *WEIGHT loss, *PEOPLE with diabetes, *CARDIOVASCULAR diseases, *DISEASE risk factors
Abstract

The article focuses on a study that assesses the effect of sibutramine use on weight loss in type 2 diabetic patients. It states that subjects in this study entered an initial single-blind, 6-week lead-in period with sibutramine and weight management. Diabetics with cardiovascular disease and another risk factor are the eligible patients in the study.

Published
2007

9. Waist circumference thresholds provide an accurate and widely applicable method for the discrimination of diabetes.

Author

Huxley R, Barzi F, Lee CM, Lear S, Shaw J, Lam TH, Caterson I, Azizi F, Patel J, Suriyawongpaisal P, Oh SW, Kang JH, Gill T, Zimmet P, James PT, and Woodward M

Subjects
Asian People ethnology, Australia, Blood Pressure, Body Mass Index, Body Weight, Ethnicity, Female, Humans, Male, Obesity classification, Odds Ratio, Overweight classification, Overweight physiopathology, Reproducibility of Results, Risk Factors, White People, Body Size, Diabetes Mellitus, Type 2 epidemiology, Obesity physiopathology
Published
2007
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results